This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Reprieve Cardiovascular, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Zoar Engelman in Heart Failure Treatment
Introduction
Zoar Engelman is an innovative inventor based in New York, NY (US). He has made significant contributions to the medical field, particularly in the treatment of acute decompensated heart failure. His work focuses on developing methods and systems that enhance patient care and improve health outcomes.
Latest Patents
Engelman holds a patent for a method and system to treat acute decompensated heart failure. This patent outlines an apparatus and method designed to assist patients suffering from acute decompensated heart failure (ADHF) or other fluid overload conditions. The process involves administering a diuretic to increase urine output, monitoring the patient's urine output, infusing a hydration liquid to further enhance urine output, and adjusting the infusion rate to achieve target fluid loss. He has 1 patent related to this innovative treatment.
Career Highlights
Zoar Engelman is currently associated with Reprieve Cardiovascular, Inc., where he continues to work on advancements in cardiovascular health. His dedication to improving treatment methods for heart failure patients showcases his commitment to medical innovation.
Collaborations
Engelman collaborates with notable professionals in the field, including Howard R Levin and Andrew Victor Halpert. These partnerships enhance the development and implementation of his innovative solutions.
Conclusion
Zoar Engelman's contributions to the treatment of heart failure exemplify the impact of innovation in healthcare. His patent and ongoing work at Reprieve Cardiovascular, Inc. highlight the importance of advancements in medical technology.